MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
Clinical trial NCT01691859 · COMPLETED
Trial details
- NCT number
- NCT01691859
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-28
- Primary completion
- 2017-05-31
- Enrollment
- 347
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.